Physician profile
Joan Crawford
NPI 1124077953
$76,956.73
in general payments reported to CMS, 2019-2025
25 companies · $1,160 in 2025
The $1,160 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $7,563 · 2021: $14K · 2022: $3,418 · 2023: $14K · 2024: $15K · 2025: $1,160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Food and Beverage: $3,387 · Travel and Lodging: $2,769 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,655.00 |
| Food and Beverage | $3,387.41 |
| Travel and Lodging | $2,768.76 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $71,756.07 | 2019-2024 | Definity |
| Abbott Laboratories | $973.15 | 2019-2024 | Cardiomems, Amplatzer Talisman |
| Boston Scientific Corporation | $659.56 | 2020-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $480.50 | 2019-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $377.08 | 2024-2025 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $373.12 | 2019-2025 | Opsumit, Uptravi |
| Shockwave Medical, INC | $338.95 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $278.17 | 2022-2025 | Interstim |
| Inari Medical, INC. | $196.78 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $179.62 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.48 | 2025 | Jardiance |
| Merck Sharp & Dohme LLC | $135.59 | 2023-2025 | Verquvo |
| Atricure, INC. | $134.12 | 2021 | |
| Abiomed | $132.04 | 2023 | Impella |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $120.00 | 2025 | |
| Cardiva Medical, INC. | $117.69 | 2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Ablative Solutions, INC. | $109.71 | 2022 | |
| Preventice Services, LLC | $88.05 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $82.67 | 2022-2025 | Camzyos |
| Biosense Webster, INC. | $61.11 | 2024-2025 | Carto 3 |
| Heartflow, INC. | $46.73 | 2023-2025 | Ffrct |
| Pfizer INC. | $27.50 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $13.83 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Crawford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.